Neuroplast

Geleen, The Netherlands

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

$11.3M raised

Nov 2021

Series B

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Neuroplast raised?

Neuroplast has raised $11.3M in total funding. The most recent round was Series B. The last funding was announced in November 2021.

Who are Neuroplast's investors?

Neuroplast's investors include Brightlands Venture Partners, Lumana Invest, NV Industriebank LIOF.

Where is Neuroplast headquartered?

Neuroplast is headquartered in Geleen, The Netherlands.

What does Neuroplast do?

Neuro-regenerative personalized medicine is one of the most promising therapies, which needs dedicated uniform standards and regulations.

What stage is Neuroplast at?

Neuroplast is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 17, 2021.

MLA

"Neuroplast — Funding & Investors." VCBacked, November 17, 2021, https://www.vcbacked.co/company/neuroplast. Accessed July 2, 2026.

APA

VCBacked. (2021). Neuroplast — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/neuroplast

Wikipedia (cite web)

{{cite web |title=Neuroplast — Funding & Investors |url=https://www.vcbacked.co/company/neuroplast |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 17, 2021.